GF Securities

GF Securities Co., Ltd. is a prominent investment banking firm based in Guangzhou, China, established in 1993. The company offers a comprehensive range of capital market services tailored to corporations, individuals, institutional investors, financial institutions, and government clients. Its operations are divided into four main segments: Investment Banking, Wealth Management, Trading and Institution, and Investment Management. In Investment Banking, GF Securities provides advisory services for mergers and acquisitions, as well as equity and debt financing. The Wealth Management segment offers brokerage services for various financial instruments, alongside margin financing and securities lending. The Trading and Institution segment focuses on trading equities, fixed income, and derivatives, while providing transaction consultation and investment research. Lastly, the Investment Management segment encompasses asset management and mutual fund management, including services related to commodities and financial futures brokerage, investment consulting, and trust management. Through its diverse offerings, GF Securities aims to deliver innovative solutions in the capital markets.

Evan Shen

Equity Research Analyst

42 past transactions

Viiyong

Series B in 2022
Viiyong is a manufacturer specializing in multi-layer ceramic chip capacitors. The company emphasizes research and development to create high-end ceramic capacitors, targeting applications primarily within the automotive electronics sector. By focusing on advanced technology and innovative solutions, Viiyong aims to meet the demands of modern electronics, providing reliable and efficient capacitor products to its customers.

Volastra

Seed Round in 2020
Volastra Therapeutics, Inc., a biotechnology company, develops therapies for the treatment of metastatic cancers. The company offers a library of organoids derived from metastatic cancer samples to elucidate how tumors spread and devise therapeutic strategies that target chromosomal instability during the process of cancer metastasis. Volastra Therapeutics, Inc. was incorporated in 2019 and is based in New York, New York.

Pi Therapeutics

Series B in 2019
Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and has operated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.

Sitka Biopharma

Venture Round in 2018
Sitka Biopharma Inc. is a preclinical biotechnology company based in Vancouver, Canada, established in 2013. The company specializes in developing a nanoparticle platform technology aimed at improving drug absorption in challenging tissues. Its primary focus is on oncology, with its lead candidate, STK-01, designed to enhance the effectiveness of intravesical chemotherapy for bladder cancer. This technology addresses significant issues related to limited drug uptake and tolerability in current treatment options. Sitka's innovative approach seeks to deliver higher concentrations of the chemotherapeutic agent docetaxel directly into the bladder wall, which may lead to better treatment outcomes. The company plans to expand its applications to intraperitoneal delivery for ovarian cancer, demonstrating the versatility of its nanoparticle platform in treating localized diseases effectively.

Chinac.com

Series E in 2018
Chinac.com, founded in 2010 and headquartered in Wuxi City, China, is a prominent provider of cloud-based information technology solutions and outsourcing services. The company specializes in the research, development, and operation of commercial cloud computing infrastructure, catering to both domestic and global clients. Chinac.com operates as a SaaS and PaaS provider, offering a range of services that support online gaming, e-commerce, mobile internet, online education, and social networking, among others. With a robust infrastructure that includes tens of thousands of physical server clusters and 20 data centers across more than 15 cities, Chinac.com ensures reliable services through its extensive network that encompasses major telecommunications providers. This positioning allows the company to deliver efficient and flexible IT infrastructure services tailored to the needs of software development companies and system integrators.

Canary Medical

Funding Round in 2018
Canary Medical Inc. specializes in the development of medical implant and data management devices that facilitate remote patient monitoring and data collection. The company's primary innovation is the Canary Health Implantable Reporting Processor (CHIRP), a sensor-based device designed to gather and process medical data without requiring direct physician intervention. Additionally, Canary Medical creates smart medical devices that provide self-reports on patient activity, recovery, and treatment outcomes, thereby enhancing patient compliance. Established in 2013 and headquartered in Vancouver, Canada, the company has also formed a joint venture with BioScience Managers to launch CHARM Informatics, a platform aimed at collecting and monetizing data from implantable and wearable medical devices.

Canary Medical

Venture Round in 2018
Canary Medical Inc. specializes in the development of medical implant and data management devices that facilitate remote patient monitoring and data collection. The company's primary innovation is the Canary Health Implantable Reporting Processor (CHIRP), a sensor-based device designed to gather and process medical data without requiring direct physician intervention. Additionally, Canary Medical creates smart medical devices that provide self-reports on patient activity, recovery, and treatment outcomes, thereby enhancing patient compliance. Established in 2013 and headquartered in Vancouver, Canada, the company has also formed a joint venture with BioScience Managers to launch CHARM Informatics, a platform aimed at collecting and monetizing data from implantable and wearable medical devices.

ARTMS

Venture Round in 2017
ARTMS Products Inc. is a Vancouver-based company that specializes in manufacturing diagnostic imaging systems for the production and separation of medical isotopes. Founded in 2013, the company has developed the QUANTM Irradiation System, which facilitates decentralized and local production of critical isotopes such as gallium-68, zirconium-89, technetium-99m, and copper-64. ARTMS's primary offering, QUANTM99, is a system that combines hardware and consumables for the effective production of technetium-99m using medical cyclotrons. This innovative approach aims to enhance the accessibility and cost-effectiveness of medical isotopes, improving diagnostic imaging services.

Bioarray Therapeutics

Series B in 2017
Bioarray Therapeutics, Inc. is a biotechnology company founded in 2009, initially based in Boston and now located in Farmington, Connecticut. The company focuses on developing proprietary predictive diagnostic tests aimed at improving cancer treatment outcomes. Its primary product is a breast cancer response prediction test that utilizes gene expression profiling to evaluate a patient's likelihood of responding to standard pre-surgery taxane-based chemotherapy. By identifying the most effective treatment options based on genetic markers, Bioarray Therapeutics seeks to move away from the traditional trial-and-error approach in cancer care, enhancing the personalization of treatment for patients.

Fotor

Series B in 2017
Fotor is an online multi-platform photo editing tool. It gains popularity with optimized and user-friendly desktop suit for both Windows and Mac, Fotor now supports every major mobile and desktop platform from Android to iOS, with a specialized Fotor for Messenger version, streamlined with Facebook for connectivity and convenience. Fotor comprises of many features such as photo editing, photo collage, graphic design, HDR, and beauty retouching. Digital editing services that includes resizing, cropping, and straightening and a wide range of filters and effects such as lomo effects, cool effects, funky effects, and blur effects are offered through the platform. Designing of a collage expresses stories, special feelings, and even captures an individual’s life. The sub categories of collage are photo stitching and funky collages. It also helps individuals design Twitter covers, YouTube channel art, Facebook covers, Google Plus covers, and a photo montages. HDR Photography utilizes different level of light exposure to enhance an image. Beauty retouching comprises of photo correcting services such as wrinkle remover, photo reshaping, blemish remover, and teeth whitener. Fotor is a China-based company that was launched in 2012.

PhysIQ

Series B in 2017
Physiq, Inc. is a health technology company based in Chicago, Illinois, that specializes in personalized physiology analytics through its cloud-based predictive platform. The company has developed VitaLink, a remote patient monitoring interface that equips clinicians with insights into the health status of patients with chronic illnesses while in an ambulatory setting. Its technology processes various data streams to establish an individual's normal baseline, enabling the detection of significant changes in vital signs that may indicate impending medical events. This personalized approach allows healthcare providers to manage patient care more effectively and empowers individuals to take charge of their health and fitness. Additionally, Physiq's platform can be integrated into monitoring devices from other manufacturers, enhancing their capabilities. Founded in 2013 and initially known as VGBio, Inc., Physiq operates in both regulated healthcare and the health and fitness markets.

PHEMI

Series B in 2017
PHEMI Systems Corporation specializes in developing a privacy, security, governance, and data management system tailored for Microsoft Azure. Founded in 2013 and based in Vancouver, Canada, the company provides the PHEMI Data Privacy Manager, a cloud-based solution designed for the healthcare sector. This system addresses the critical need for organizations to secure and govern access to privacy-sensitive information while facilitating compliance with privacy regulations. Optimized for Microsoft Azure, the software connects to numerous data sources and integrates seamlessly with popular data science and business analysis tools. Built on a privacy-by-design architecture, PHEMI Data Privacy Manager supports data sharing and offers a flexible usage-based pricing model, making it scalable for organizations of varying sizes.

Eloxx

Series C in 2017
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel ribonucleic acid modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial that focuses on the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is headquartered in Waltham, Massachusetts.

Lyndra Therapeutics

Series A in 2017
Lyndra Therapeutics, Inc. specializes in the development of ultra-long-acting oral medications that provide sustained drug release over extended periods, ranging from a week to a month. By focusing on orally administered dosage forms that temporarily reside in the stomach, the company aims to transform the way medicines are taken, reducing the need for daily pills. Its portfolio includes therapies targeting a variety of health conditions, such as Alzheimer's disease, cardiovascular and metabolic disorders, psychiatric and opioid use disorders, immunology, HIV, malaria vector control, and oral contraceptives. Founded in 2015 and headquartered in Watertown, Massachusetts, Lyndra Therapeutics is committed to enhancing medication adherence and improving health outcomes while also aiming to lower healthcare costs through innovative delivery methods.

PingPong

Series B in 2017
PingPong is a payment facilitator designed for China-based eCommerce sellers, offering a cross-border payment platform that enables users to sell globally. The company provides tailored payment services, including a one-click withdrawal feature that allows users to transfer funds directly to domestic bank accounts without incurring foreign exchange losses or additional charges. By simplifying the payment process, PingPong aims to empower its customers and help them expand their businesses internationally. The company emphasizes ethical standards and effective communication to overcome barriers in global commerce, fostering a culture that values curiosity and results-driven approaches. As a rapidly growing fintech startup, PingPong is committed to making an impact in the eCommerce sector.

Biscayne Pharmaceuticals

Series B in 2017
Biscayne Pharmaceuticals, Inc. is a biopharmaceutical company based in Miami, Florida, focused on developing therapies that leverage growth hormone-releasing hormone (GHRH) analogs. The company is engaged in creating GHRH antagonists aimed at treating various cancers, including castrate-resistant prostate cancer, and GHRH agonists intended for cardiac repair in patients with heart disease. Additionally, Biscayne Pharmaceuticals is involved in developing drugs for refractory epilepsy and drug-resistant cancer by targeting GHRH receptors, which play a critical role in stimulating growth hormone production for tissue growth and repair. Since its incorporation in 2012, the company has aimed to provide innovative treatments for patients with challenging medical conditions.

iGola

Series A in 2016
Guangzhou iGola Information Technology Consulting Services Co., Ltd., founded in 2014 and based in China, operates iGola, a smart metasearch engine for international air travel. The platform enables users to search for and book air tickets from a wide range of providers globally. iGola offers live price comparisons and streamlined booking processes, allowing travelers to access hundreds of airlines without the need for redirection. The user experience is designed to be clean and intuitive, facilitating an efficient booking process for international flights.

Helowin

Series E in 2016
Zhejiang Helowin Medical Technology Co., Ltd. is a software company specializing in healthcare and is headquartered in China.
Liaoning Chengda Biotechnology Co., Ltd. is a Shenyang-based company established in 2002 that specializes in the research, development, production, and sale of virus vaccines for human use in China. The company primarily offers rabies and Japanese encephalitis vaccines, with an annual production capacity of 10 million doses for each vaccine. Chengda's rabies vaccine has a strong presence in the domestic market and is exported to several countries, including India, Pakistan, and Thailand. The company operates a large production facility in the National High-tech Park of Weinan, covering nearly 100 acres, and employs over 800 staff. Chengda is also developing new vaccines, including a bivalent renal syndrome hemorrhagic fever vaccine, which is expected to complete clinical research and obtain production approval soon. The company emphasizes its commitment to high-quality standards and has successfully passed national GMP certification. Liaoning Chengda Biotechnology aims to uphold its values of integrity and responsibility while expanding its product line to meet the growing demands of the immunization program in China and beyond.

Xuanwu Technology

Post in 2016
Xuan Wu Cloud Technology Holdings Ltd is an intelligent CRM services provider, providing CRM PaaS services and CRM SaaS services to clients. its CRM PaaS services mainly provide cPaaS to encapsulate messaging communication capabilities of the three telecommunication network operators for the customers to be integrated into the customer's business systems, thereby enabling the customers to access and utilize the communication capabilities as a service, and CRM SaaS services comprise of marketing cloud, sales cloud, and service cloud, which enable the Group to provide the customer with one-stop intelligent CRM services throughout their entire business cycle, from initialmore

KOTEI

Post in 2016
Wuhan Kotei Informatics Co., Ltd. develops software solutions for smart cars and smart cities. The company offers navigation software for smart cars and mapping and navigation software application for smart-phones. It also offers industry specific navigation systems customizing aerial photo displays and business flow processing features for power, logistics, and law enforcement industries. Additionally, it offers smart city management solutions; smart land supervision and monitoring solutions; tourism data center and distribution system for smart tourism; tax control and tax source management systems; and smart logistics systems. Wuhan Kotei Informatics Co., Ltd. was founded in 2011 and is based in Wuhan, China.

Since Times

Post in 2016
Developer of online games intended for Tencent platform. The company focuses on developing social games, mobile games, and web games, providing entertainment value for gamers on the Tencent platform.

Tellyes Scientific

Post in 2015
Tellyes Scientific Inc. is a manufacturer and marketer of healthcare equipment designed for medical education and training. Established in 2001 and based in Tianjin, China, the company specializes in a range of products, including patient simulators, surgical simulators, ultrasound and imaging simulators, task trainers, and dental simulators. Tellyes Scientific aims to enhance medical teaching capabilities by providing realistic simulation tools for research organizations, medical colleges, and hospitals. In addition to its product offerings, the company provides solutions for planning and building training centers, managing training centers, and tele-simulation. Its products are distributed across various regions, including Asia, Africa, the Middle East, Europe, North America, and Latin America.

Tiandi

Post in 2015
Tiandi No.1 Beverage Inc., along with its subsidiaries, produces and sells vinegar drinks and other beverages. The company offers apple vinegar cider under various brands such as, One Heaven And Earth among others. It serves ​​Hunan, Hubei, Anhui, Jiangxi, Jiangsu, Fujian, Hainan, Guangxi, and Henan provinces in China. The company was founded in 1997 and is based in Guangzhou, China with production bases in Guangdong, Hebei, and Jiangxi, China.

Centran

Post in 2015
Centran Technology Co.,Ltd offers IT consulting services, which includes production and sale of software products and system integration services. Centran Technology Co.,Ltd was founded in 2009 and is headquartered in Beijing, China.

Launch Design

Post in 2015
Shanghai Launch Automotive Technology Co., Ltd specializes in contract automotive design and component design services for both domestic and international automobile manufacturers. Founded in 2000 and based in Shanghai, the company offers a range of services including automotive design advisory solutions, vehicle integration, and engineering development. With a professional technology team that possesses expertise in whole vehicle model design and design verification, Launch Automotive supports auto production enterprises with long-term research and development, as well as consulting services. The company was formerly known as Shanghai Longchuang Automobile Design Co., Ltd before rebranding in January 2015.
Dongyang Kingrain Media Co., Ltd. produces television dramas. The company also offers distribution and licensing services for TV series. In addition, it offers advertising services. Dongyang Kingrain Media Co., Ltd. was founded in 2007 and is based in Beijing, China.

Guangyuyuan

Post in 1996
GuangYuYuan Chinese Herbal Medicine Co., Ltd. manufactures and sells Chinese medicinal products. The company offers traditional Chinese medicines and health wines. It offers its products in the form of pills, capsules, and wine. The company was formerly known as Topsun Science And Technology Co Ltd. and changed its name to GuangYuYuan Chinese Herbal Medicine Co., Ltd. in July 2013. GuangYuYuan Chinese Herbal Medicine Co., Ltd. was founded in 1996 and is based in Xi'an, China.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.